Completed NA INTERVENTIONAL 3-arm NCT04619875

A Clinical Study to Assess the Effect of Increasing Intake Amounts of Two Novel Glycans on the Gut Microbiota of Healthy Subjects

A Randomized, Open Label Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect of Increasing Intake Amounts of Two Novel Glycans on the Gut Microbiota of Healthy Subjects

Sponsor: Kaleido Biosciences

Conditions Healthy

Interventions KB5 Lactulose SG1

Updated 4 times since 2020 Last updated: Nov 3, 2020 Started: Sep 11, 2017 Primary completion: Nov 21, 2017 Completion: Nov 21, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Healthy, this trial is completed. The trial is conducted by Kaleido Biosciences and has accumulated 4 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Dec 2020 — Jan 2021 [monthly]

Completed NA

First recorded

Sep 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kaleido Biosciences

Data source: Kaleido Biosciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Addison, United States